Novo M, Frascione PMM, Castellino A, Marcheselli L, et al. Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL). Br J Haematol 2025 Jun 10. doi: 10.1111/bjh.20204.
PMID: 40495420